marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
PTC Therapeutics Financial Ratios 2011-2024 | PTCT
Annual Financial Ratios PTC Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.4 | -5.8 | -4.7 | -8.6 | -12.0 | -10.9 | -13.2 | -2.9 | -4.7 | -18.5 | -6.7 | - | - |
P/S |
2.3 | 4.6 | 4.6 | 9.9 | 9.8 | 5.3 | 5.4 | 5.0 | 21.8 | 75.5 | 11.0 | - | - |
EPS |
-8.4 | -7.8 | -7.4 | -6.6 | -4.3 | -2.8 | -2.0 | -4.2 | -5.1 | -3.0 | -5.2 | 219.8 | 23.9 |
EV (Enterprise Value) |
4.25 B | 5.02 B | 4.21 B | 5.28 B | 3.76 B | 1.99 B | 1.17 B | 507 M | 885 M | 1.72 B | 344 M | 29.5 M | 254 M |
EBITDA per Share |
-2.71 | -4.44 | -4.4 | -5.88 | -2.81 | -1.58 | -1.25 | -3.78 | -4.88 | -3.08 | -3.35 | - | - |
EV/EBITDA |
-13.6 | -11.2 | -18.4 | -18.7 | -22.1 | -3.5 | -5.1 | -17.3 | -7.6 | - | - | ||
PEG |
-0.14 | -0.15 | -0.19 | -0.35 | 0.22 | 0.3 | -0.26 | -0.16 | 0.07 | -0.43 | 0.04 | - | - |
P/B |
-2.6 | -9.4 | 1721.0 | 7.8 | 5.1 | 4.0 | 6.7 | 3.5 | 3.5 | 5.8 | 2.5 | - | - |
P/CF |
-13.4 | -9.1 | -9.8 | -19.4 | -20.9 | -32.3 | -79.4 | -3.9 | -6.3 | -28.0 | -7.2 | - | - |
ROE % |
76.55 | 161.06 | -36432.61 | -90.91 | -42.33 | -36.52 | -50.50 | -118.84 | -75.42 | -31.41 | -37.77 | - | - |
ROA % |
-33.05 | -32.78 | -27.03 | -19.84 | -15.49 | -11.44 | -20.17 | -52.76 | -46.31 | -28.14 | -33.95 | - | - |
ROCE % |
53.69 | 128.90 | -26039.15 | -89.58 | -13.89 | -10.12 | -20.77 | -60.10 | -51.80 | -33.06 | -32.71 | - | - |
Current Ratio |
0.7 | 0.8 | 1.0 | 1.3 | 3.3 | 1.9 | 3.0 | 5.3 | 7.8 | 10.0 | 11.0 | - | - |
DSO |
61.6 | 69.5 | 61.1 | 60.1 | 66.0 | 93.6 | 75.8 | 110.0 | 110.1 | 70.7 | 11.2 | - | - |
DIO |
- | - | - | - | 580.1 | 464.3 | 857.6 | - | - | - | - | - | - |
DPO |
- | - | - | - | 310.5 | 172.9 | 1218.7 | - | - | - | - | - | - |
Operating Cycle |
61.6 | 69.5 | 61.1 | 60.1 | 646.1 | 557.9 | 933.4 | - | - | - | - | - | - |
Cash Conversion Cycle |
61.6 | 69.5 | 61.1 | 60.1 | 335.6 | 385.1 | -285.2 | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios PTC Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.39 | -1.29 | -1.2 | - | -1.76 | -2.66 | -1.88 | - | -1.53 | -2.13 | -1.78 | - | -1.89 | -1.68 | -1.83 | -1.08 | -1.03 | -2.78 | -1.81 | -1.37 | -1.06 | -0.75 | -1.29 | 0.96 | -1.06 | -0.21 | -0.46 | 0.03 | -0.82 | -0.44 | -0.85 | -0.78 | -1.03 | -1.14 | -1.22 | -1.5 | -1.27 | -1.14 | -1.15 | -0.84 | -0.93 | -0.86 | -0.58 | -0.75 | -0.19 | -5.51 | -6527.3 | -1380.13 | -1605.53 | 168 | -5992.61 | - | - | - | - |
EBITDA per Share |
-0.67 | -0.49 | 0.13 | - | -0.79 | -2.17 | -1.01 | - | -0.52 | -0.93 | -0.85 | - | -0.68 | -1.22 | -1.2 | -1.38 | -0.36 | -2.58 | -1.34 | -1.18 | -0.67 | -0.43 | -1.11 | -0.89 | -0.6 | 0.14 | -0.26 | 0.13 | -0.46 | -0.28 | -0.75 | -0.73 | -0.87 | -1.03 | -1.11 | -1.42 | -1.18 | -1.11 | -1.13 | -0.98 | -0.88 | -0.83 | -0.56 | -0.76 | -0.1 | -5 | -1.76 K | -1.33 K | -1.1 K | -1.98 K | - | - | - | - | - |
ROE % |
50.30 | 60.01 | 84.22 | 84.53 | 132.70 | 161.06 | 210.19 | 271.54 | 144.19 | -31.33 | -175.01 | -231.54 | -246.96 | -134.07 | -111.50 | -90.91 | -88.55 | -84.19 | -53.58 | -42.33 | -43.04 | -47.48 | -43.16 | -36.52 | -21.93 | -28.96 | -37.42 | -50.50 | -73.72 | -81.56 | -102.93 | -118.84 | -118.97 | -108.69 | -93.12 | -75.42 | -62.01 | -52.03 | -43.46 | -31.41 | -35.37 | -29.47 | -31.74 | -37.77 | -18.38 | -7.82 | 8.95 | 19.71 | 13.41 | 6.09 | - | - | - | - | - |
ROA % |
-26.64 | -31.40 | -41.09 | -34.05 | -40.99 | -37.37 | -29.55 | -21.02 | -27.68 | -20.36 | -26.11 | -18.50 | -21.86 | -18.36 | -20.83 | -19.84 | -21.26 | -21.80 | -16.16 | -15.49 | -15.03 | -15.89 | -14.16 | -11.44 | -6.80 | -10.86 | -14.47 | -20.17 | -30.44 | -34.89 | -44.87 | -52.76 | -56.76 | -55.54 | -51.59 | -46.66 | -40.90 | -37.25 | -34.28 | -28.14 | -31.73 | -26.45 | -28.52 | -33.95 | -70.16 | -123.07 | -159.89 | -150.22 | -102.24 | -46.42 | - | - | - | - | - |
ROCE % |
31.97 | 44.42 | 76.49 | 79.49 | 109.54 | 121.98 | 136.49 | 176.26 | 87.55 | -31.21 | -132.00 | -172.36 | -192.35 | -115.08 | -103.83 | -89.58 | -81.83 | -80.57 | -48.24 | -40.58 | -41.20 | -44.78 | -39.84 | -32.98 | -16.63 | -22.63 | -29.02 | -41.10 | -65.48 | -72.55 | -95.13 | -110.43 | -110.86 | -102.73 | -89.25 | -73.95 | -63.42 | -53.98 | -45.39 | -33.31 | -35.76 | -29.64 | -31.73 | -33.25 | -13.94 | -3.73 | 14.38 | 20.66 | 14.61 | 7.53 | - | - | - | - | - |
Current Ratio |
0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 | 0.9 | - | 0.9 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.8 | 1.8 | 1.8 | 2.6 | 2.6 | 2.6 | 2.6 | 9.6 | 9.6 | 9.6 | 9.6 | 9.9 | 9.9 | 9.9 | 9.9 | 0.4 | 0.4 | 0.4 | - | - | - | - | - |
DSO |
89.8 | 94.0 | 77.8 | - | 79.7 | 81.0 | 74.0 | - | 26.1 | 38.9 | 77.2 | - | 57.7 | 67.6 | 63.5 | - | 53.9 | 84.8 | 83.9 | - | 71.0 | 59.3 | 105.1 | 72.2 | 115.6 | 90.1 | 88.1 | 63.6 | 88.1 | 76.8 | 112.3 | - | 99.0 | 145.5 | 87.0 | - | 103.5 | 149.4 | 94.8 | - | 239.4 | 241.9 | 26.8 | 9.9 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 585.4 | 548.0 | 679.8 | - | 446.7 | 571.8 | 402.6 | - | 620.3 | 1294.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 313.4 | 293.4 | 313.5 | - | 166.3 | 212.9 | 318.9 | - | 881.5 | 1839.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
89.8 | 94.0 | 77.8 | - | 79.7 | 81.0 | 74.0 | - | 26.1 | 38.9 | 77.2 | - | 57.7 | 67.6 | 63.5 | - | 53.9 | 84.8 | 83.9 | - | 656.4 | 607.3 | 784.9 | 72.2 | 562.4 | 661.9 | 490.8 | 63.6 | 708.4 | 1371.4 | 112.3 | - | 99.0 | 145.5 | 87.0 | - | 103.5 | 149.4 | 94.8 | - | 239.4 | 241.9 | 26.8 | 9.9 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
89.8 | 94.0 | 77.8 | - | 79.7 | 81.0 | 74.0 | - | 26.1 | 38.9 | 77.2 | - | 57.7 | 67.6 | 63.5 | - | 53.9 | 84.8 | 83.9 | - | 343.0 | 313.9 | 471.4 | 72.2 | 396.0 | 449.0 | 171.9 | 63.6 | -173.1 | -468.2 | 112.3 | - | 99.0 | 145.5 | 87.0 | - | 103.5 | 149.4 | 94.8 | - | 239.4 | 241.9 | 26.8 | 9.9 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency